https://www.cidrap.umn.edu/news-per...id-19-survivors-report-symptoms-2-years-later
Study: 20% of COVID-19 survivors report symptoms 2 years later
Filed Under:
COVID-19
Mary Van Beusekom | News Writer | CIDRAP News
Sep 16, 2022
Two years after hospital release, nearly 20% of COVID-19 survivors in Wuhan, China, reported persistent, new-onset, or worsening symptoms, finds a study published yesterday in JAMA Network Open.
The researchers conducted phone interviews of 1,864 COVID-19 survivors 1 and 2 years after release from one of two hospitals in Wuhan from Feb 12 to Apr 10, 2020, a period dominated by the wild-type virus and preceding the availability of vaccines. Participants also completed a symptom questionnaire and underwent a chronic obstructive pulmonary disease assessment test (CAT) at both time points.
8% had new-onset or worsening symptoms
The median patient age was 58.5 years, 49.7% were men, 27.1% had been severely ill, and the median hospital stay was 14 days. While hospitalized, 95.3% of patients had at least one COVID-19 symptom, and 71.9% received oxygen therapy (0.8% of whom received mechanical ventilation), and 1.9% were admitted to an intensive care unit (ICU).
At 2 years, 19.8% of patients reported long-COVID symptoms, including 12.0% with lingering symptoms and 7.8% with new-onset or worsening symptoms.
The most common persistent symptoms were fatigue, chest tightness, anxiety, shortness of breath, and muscle pain, while common new-onset symptoms were fatigue, anxiety, chest tightness, and productive cough. At both time points, fatigue was the most common symptom but decreased from 26.9% at 1 year to 10.3% at 2 years.
The percentage of patients with long-COVID symptoms continuously decreased over time (43.2% at 1 year vs 19.8% at 2 years). The decline was observed in patients with both severe and milder illness and was greater in those with severe disease.
Among patients reporting symptoms at 2 years, 12.2% reported one symptom, 4.5% reported two, and 3.2% said they had three or more. While most symptoms improved over time, shortness of breath remained at roughly the same low level, affecting 2.6% of participants at 1 year and 2.0% at 2 years.
Severely ill patients at highest risk
The median CAT score at 2 years was 2, indicating low impact on quality of life, but it rose to 3 in severely ill patients. A total of 6.2% of participants had total CAT scores of 10 or higher, indicating a medium impact on quality of life.
The CAT scores suggest that patients had more sleep disorders and low energy levels than other symptoms, the researchers said. After multivariable adjustment, older age (odds ratio [OR], 1.04), ICU admission (OR, 2.83), and chronic liver disease (OR, 2.18) were tied to CAT scores of 10 or higher.
Severely ill patients were more likely to have persistent symptoms at 2 years (severe vs nonsevere, 17.6% vs 9.9%) and were less likely to report no symptoms (41.0% vs 51.9%). Patients admitted to an ICU were at higher risk for persistent symptoms than their less severely ill peers (OR, 2.69) and of having CAT scores of 10 or higher (OR, 2.83).
The study authors said the findings provide valuable information about the dynamics of long COVID over time but added that important questions remain about new-onset symptoms.
"Patients with coexisting cerebrovascular disease had more coexisting disorders of other organ systems, which raised the possibility that diseases other than COVID-19 may have been associated with the new-onset symptoms, so it is difficult to determine whether new-onset symptoms were completely attributable to long COVID-19," they wrote.
Study: 20% of COVID-19 survivors report symptoms 2 years later
Filed Under:
COVID-19
Mary Van Beusekom | News Writer | CIDRAP News
Sep 16, 2022
Two years after hospital release, nearly 20% of COVID-19 survivors in Wuhan, China, reported persistent, new-onset, or worsening symptoms, finds a study published yesterday in JAMA Network Open.
The researchers conducted phone interviews of 1,864 COVID-19 survivors 1 and 2 years after release from one of two hospitals in Wuhan from Feb 12 to Apr 10, 2020, a period dominated by the wild-type virus and preceding the availability of vaccines. Participants also completed a symptom questionnaire and underwent a chronic obstructive pulmonary disease assessment test (CAT) at both time points.
8% had new-onset or worsening symptoms
The median patient age was 58.5 years, 49.7% were men, 27.1% had been severely ill, and the median hospital stay was 14 days. While hospitalized, 95.3% of patients had at least one COVID-19 symptom, and 71.9% received oxygen therapy (0.8% of whom received mechanical ventilation), and 1.9% were admitted to an intensive care unit (ICU).
At 2 years, 19.8% of patients reported long-COVID symptoms, including 12.0% with lingering symptoms and 7.8% with new-onset or worsening symptoms.
The most common persistent symptoms were fatigue, chest tightness, anxiety, shortness of breath, and muscle pain, while common new-onset symptoms were fatigue, anxiety, chest tightness, and productive cough. At both time points, fatigue was the most common symptom but decreased from 26.9% at 1 year to 10.3% at 2 years.
The percentage of patients with long-COVID symptoms continuously decreased over time (43.2% at 1 year vs 19.8% at 2 years). The decline was observed in patients with both severe and milder illness and was greater in those with severe disease.
Among patients reporting symptoms at 2 years, 12.2% reported one symptom, 4.5% reported two, and 3.2% said they had three or more. While most symptoms improved over time, shortness of breath remained at roughly the same low level, affecting 2.6% of participants at 1 year and 2.0% at 2 years.
Severely ill patients at highest risk
The median CAT score at 2 years was 2, indicating low impact on quality of life, but it rose to 3 in severely ill patients. A total of 6.2% of participants had total CAT scores of 10 or higher, indicating a medium impact on quality of life.
The CAT scores suggest that patients had more sleep disorders and low energy levels than other symptoms, the researchers said. After multivariable adjustment, older age (odds ratio [OR], 1.04), ICU admission (OR, 2.83), and chronic liver disease (OR, 2.18) were tied to CAT scores of 10 or higher.
Severely ill patients were more likely to have persistent symptoms at 2 years (severe vs nonsevere, 17.6% vs 9.9%) and were less likely to report no symptoms (41.0% vs 51.9%). Patients admitted to an ICU were at higher risk for persistent symptoms than their less severely ill peers (OR, 2.69) and of having CAT scores of 10 or higher (OR, 2.83).
The study authors said the findings provide valuable information about the dynamics of long COVID over time but added that important questions remain about new-onset symptoms.
"Patients with coexisting cerebrovascular disease had more coexisting disorders of other organ systems, which raised the possibility that diseases other than COVID-19 may have been associated with the new-onset symptoms, so it is difficult to determine whether new-onset symptoms were completely attributable to long COVID-19," they wrote.